F-18 FDG PET Findings for Vogt-Koyanagi-Harada Disease
نویسندگان
چکیده
منابع مشابه
Vogt-Koyanagi-Harada disease.
Vogt-Koyanagi-Harada disease is a chronic, granulomatous systemic autoimmune disease with manifestations in the ocular, central nervous, auditory, and integumentary systems. The target of attack seems to be antigens associated with melanocytes. Patients are usually of Asian, Middle Eastern, Asian Indian, Native American, or Hispanic ethnicity, and complain of neurologic symptoms quickly followe...
متن کاملVogt-Koyanagi-Harada disease.
Vogt-Koyanagi-Harada (VKH) disease, also known as uveomeningitic syndrome, is an idiopathic multisystem inflammatory disease with bilateral uveitis. Patients with bilateral anterior uveitis with vitiligo, poliosis, alopecia, and dysacousia were first described by Vogt in 1906 and then Koyanagi in 1929. Harada described a case of posterior uveitis with exudative retinal detachment and pleocytosi...
متن کاملVogt-koyanagi-harada Syndrome
CASE PRESENTATION A 20 year old Asian male was referred with the complaint of decreased vision in both eyes for a year. His past medical and surgical histories were unremarkable. His family history revealed thyroid disease in his mother. Review of systems were remarkable for alopecia and headache at the time when his eye problems began. The first eye exam from his referring ophthalmologist reve...
متن کاملVogt Koyanagi Harada syndrome.
An 11-year-old female girl presented to us with fever of 3 months duration. Additionally she had vitiligo for two years and deafness and alopecia for the last 3 months. Two years ago, the patient had an episode of pain, watering and congestion of both eyes (suggestive of nontraumatic uveitis) for 2 weeks. She responded to therapy in the form of eye drops and oral medication (Ayurvedic medicine)...
متن کاملRituximab in refractory Vogt–Koyanagi–Harada disease
INTRODUCTION Vogt-Koyanagi-Harada (VKH) prognosis depends on early recognition and treatment; chronic disease may be developed when either delayed or inadequate treatment is performed, whereas other cases despite correct treatment are refractory to different drugs and also become chronic. We report a case of refractory VKH controlled with rituximab treatment. CASE REPORT A 41-year-old female ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nuclear Medicine and Molecular Imaging
سال: 2015
ISSN: 1869-3474,1869-3482
DOI: 10.1007/s13139-015-0384-7